RBM-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RBM-001, covering 2025-08-08 to 2025-08-08. Get the full timeline:
Most recent: Clinical Trial Update: A First in Human Study to Evaluate the Safety and Immunogenicity of RBM-001 in Healthy Adult Volunteers [Phase 1]